Discover 649 paid clinical trials in Charleston, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 649
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Charleston SC, Kinston NC, Wesley Chapel FL, Tampa FL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
ViewFlex X ICE First-in-Human Study
for
Cardiac Arrhythmias
Location: Charleston SC, Jacksonville FL, Philadelphia PA,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06772493
Recruiting
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Charleston SC, Durham NC, St Louis MO, Houston TX
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05793151
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Charleston SC, Charlotte NC, Spartanburg SC,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
STRIDE Biorepository
for
Anemia, Sickle Cell
Location: Charleston SC, Augusta GA, Chapel Hill NC, Durham NC,
Sponsor: Emory University
Sex: All
Age: 15 - 40
Code: NCT02843347
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
for
Heart Failure With Preserved Ejection Fraction (HFpEF
Location: Charleston SC, Durham NC, Columbus OH, New York NY,
Sponsor: Axon Therapies, Inc.
Sex: All
Age: 40+
Code: NCT04592445
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Charleston SC, West Columbia SC, Jacksonville FL,